−84.4
Nurix Therapeutics, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
−160
FY23:
−81.4
FY24:
−173
FY25:
−249
Change from FY21 to FY25
millions USD
FY21:
−108
FY22:
27.2
FY23:
68.3
FY24:
−258
FY25:
148
Change from FY21 to FY25
millions USD
FY21:
154
FY22:
117
FY23:
3.22
FY24:
486
FY25:
239
millions USD
FY21:
−38.7
FY22:
−15.4
FY23:
−9.85
FY24:
55.4
FY25:
137
(positive)
Change from FY21 to FY25
millions USD
FY21:
−90.0
FY22:
−172
FY23:
−89.8
FY24:
−182
FY25:
−263
All amounts in millions USD